News | September 30, 2009

ASCRO Offers 'Provider Status' for Clinical Radiation Oncology Physicists

September 30, 2009 - The founding members of the American Society of Clinical Radiation Oncology (ASCRO) announced its addition as a new professional non-profit organization primarily dedicated to acquiring a "Provider Status" for clinical radiation oncology physicists.
"ASCRO believes that the quality of patient care will be significantly enhanced when clinical radiation oncology physicists are given Provider Status. Such a status will allow them to make professional decisions based solely on the best interest of cancer patients," said Nabil Adnani, Ph.D., ASCRO's president and founding member. "By joining ASCRO in large numbers, clinical radiation oncology physicists will ensure, and for the first time in history, their true place as medical professionals," Dr. Adnani went on to say.
"Finally, a long overdue society is born. Clinical Radiation Oncology Physicists now have an organization they can call their own," said Ivan Brezovich, Ph.D., ASCRO's chairman and founding member.
ASCRO will work with existing organizations and will seek advice from more established professional societies such as the American Association of Physicists in Medicine (AAPM) and the American Society for Therapeutic Radiation Oncology (ASTRO) in its efforts to obtain a "Provider Status" for its members.

ASCRO was founded in February 2009, ASCRO obtained its non-profit status in April 2009.

For more information: www.ascro.org

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...